Homologous Gene Finding with a Hidden Markov Model by Cui, Xuefeng
Homologous Gene Finding




presented to the University of Waterloo
in fulfilment of the




Waterloo, Ontario, Canada, 2006
c© Xuefeng Cui 2006
AUTHOR’S DECLARATION FOR ELECTRONIC SUBMISSION OF A THESIS
I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis,
including any required final revisions, as accepted by my examiners.
I understand that my thesis may be made electronically available to the public.
ii
Abstract
The homology search problem and the gene finding problem are two fundamental prob-
lems in bioinformatics. The homology search problem is to find the homologous regions of
two biological sequences; the gene finding problem is to find all the genes in both strands of
a genomic sequence. Recently, gene finding research has demonstrated that homology search
results can be used to improve the accuracy of gene finding. By combining the two problems,
we define a new problem called the homologous gene finding problem. The homologous gene
finding problem is to find homologous genes of a query gene in a target genomic sequence.
Consequently, we present a new homologous gene finding algorithm in this thesis. We
borrow the idea of gene mapping and alignment algorithms, and apply existing seed-based
homology search algorithms and hidden Markov model-based (HMM-based) gene finding al-
gorithms to solve the homologous gene finding problem. After we find high-scoring segment
pairs (HSPs) between the query gene and the target genomic sequence, we locate target re-
gions that we believe contain a gene homologous to the query gene. Then, we extend existing
HMM-based gene finding algorithms to find homologous gene candidates. To improve the
accuracy of homologous gene finding, we train a HMM to be biased toward the query gene.
We also introduce a new coding sequence (CDS) length penalty as a measure of how the
CDS lengths of the query gene and its homologous gene vary to further improve the accuracy.
We use the new CDS length penalty together with our enhanced Viterbi algorithm and our
flexible finish condition to improve the speed of homologous gene fining without harming
the accuracy. Finally, we use protein alignment to pick and rank the best homologous gene
candidates.
In this thesis, we also describe several experiments to evaluate and support our homolo-
gous gene finding algorithm.
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In this thesis, we introduce a new algorithm to find homologous genes from different species.
In Chapter 1, we first introduce the biological background related to our research. Then, we
define the homologous gene finding problem, and review several related problems. In Chapter
2, we introduce our homologous gene finding algorithm. In Chapter 3, we demonstrate the
usefulness of our algorithm by presenting its implementation, and evaluating its performance
on homologous gene data sets. Finally, we discuss our homologous gene finding algorithm
and future work in Chapter 4.
1.1 Genome, Gene and Protein
In this section, we introduce the complete biological background related to the homolo-
gous gene finding problem. In particular, we introduce gene structures, and the process of
producing proteins from genes.
Deoxyribonucleic acid (DNA) consists of two strands of nucleotides, joined together as a
single chain to form a double helical structure. Each DNA nucleotide consists of three com-
ponents: a sugar molecule called deoxyribose, a phosphate group, and a nitrogen-containing
compound called base. There are five carbons in the sugar molecule, and they are numbered
1′, 2′, 3′, 4′ and 5′. The hydroxyl groups on the 5′ and 3′ carbons link to the phosphate
groups to form the backbone of DNA. The 5′ end of a DNA strand is called the upstream,

















































Figure 1.1: DNA complementary base pairing
DNA: adenine (A), cytosine (C), guanine (G) and thymine (T). The two strands are joined
together by complementary base pairing: adenine always pairs with thymine, and guanine
always pairs with cytosine, as shown in Figure 1.1.
The process of DNA copying is called replication. During replication, the two strands of
the double helix structure first separate to individual strands. Then, each strand is paired
with floating complementary bases within the cell to form a new double helical structure.
Rarely, nucleotides are inserted, deleted (indel) or mutated during replication.
Ribonucleic acid (RNA) consists of a single nucleotide chain. Each RNA nucleotide
consists of three components: a sugar molecule called ribose, a phosphate group and a
nitrogen-containing compound called base. Again, there are four types of bases for RNA:
adenine (A), cytosine (C), guanine (G) and uracil (U).
The genome of an organism consists of the complete DNA sequences of the organism.
Genes are regions of the genome that encode the information to produce proteins. Human
genes have between 100 and 1,000,000 nucleotides, and their coding regions make up less
than 2 percent of the complete genome [15].
In eukaryotes, genes may contain coding regions and non-coding regions. The coding
regions are called exons, and exons are separated by non-coding regions called introns. The
boundaries of exons and introns are called splice sites. The splice site located after an exon
and before an intron is called a donor site. Otherwise, it is called an acceptor site. In
prokaryotes, there are no introns.
Generally, there are signals nearby splice sites in the genome. We used the program









































































































































































































Figure 1.3: Sequence logo of the acceptor site signal
from 100 donor sites and 100 acceptor sites of human genes. In these figures, the splice sites
are the boundaries between position -1 and position 0. Each column represents a position
around the splice site in the nucleotide sequence, and each letter represents a nucleic acid
at that position. The probability of a particular nucleic acid being observed at a position
is proportional by the height of that letter. The nucleic acid with the highest probability of
being observed at a particular position is shown on the top of that column. From Figures
1.2 and 1.3, we can see that the strongest signal is that the nucleotides “GT” always appear
right after donor sites, and the nucleotides “AG” always appear right before acceptor sites.





























Figure 1.4: Protein synthesis
The process of producing proteins from genes is called protein synthesis, and it can be
divided into two steps: transcription and translation. Figure 1.4 shows the complete process
of protein synthesis.
During the transcription, the information encoded in the DNA is transcripted to a mes-
senger RNA (mRNA). In prokaryote, this step simply copies a fragment of DNA to mRNA.
However, in eukaryotes, the gene is first copied to a preliminary mRNA (pre-mRNA), and
then introns are spliced out. The remaining exons are connected in the original order to
form a mature mRNA.
During the translation, an mRNA is translated to a protein, and Figure 1.5 shows an
example of how an mRNA sequence is translated into a protein sequence. At the 5′ and 3′
ends of an mRNA sequence, there are untranslated regions (UTR) that are not translated to
the protein. Other than UTRs, the coding sequence (CDS) is translated to the protein, and
4
2nd base
T C A G
1st T TTT Phe/F TCT Ser/S TAT Tyr/Y TGT Cys/C
base TTC Phe/F TCC Ser/S TAC Tyr/Y TGC Cys/C
TTA Leu/L TCA Ser/S TAA Stop TGA Stop
TTG Leu/L TCG Ser/S TAG Stop TGG Trp/W
C CTT Leu/L CCT Pro/P CAT His/H CGT Arg/R
CTC Leu/L CCC Pro/P CAC His/H CGC Arg/R
CTA Leu/L CCA Pro/P CAA Gln/Q CGA Arg/R
CTG Leu/L CCG Pro/P CAG Gln/Q CGG Arg/R
A ATT Ile/I ACT Thr/T AAT Asn/N AGT Ser/S
ATC Ile/I ACC Thr/T AAC Asn/N AGC Ser/S
ATA Ile/I ACA Thr/T AAA Lys/K AGA Arg/R
ATG Met/M, Start ACG Thr/T AAG Lys/K AGG Arg/R
G GTT Val/V GCT Ala/A GAT Asp/D GGT Gly/G
GTC Val/V GCC Ala/A GAC Asp/D GGC Gly/G
GTA Val/V GCA Ala/A GAA Glu/E GGA Gly/G
GTG Val/V GCG Ala/A GAG Glu/E GGG Gly/G
Table 1.1: Genetic Code







Figure 1.5: Simple translation example
a CDS is made up of nucleotide triplets called codons. Each codon has 3 frames numbered
from 1 to 3, and each codon encodes an amino acid using the Genetic Code, as shown in
Table 1.1. There are 64 possible codons, but there are only 20 amino acids. Thus, different
codons may be translated into the same amino acid. If the codon frame is shifted by one or
two, the CDS may be translated to a completely different protein with different functions.
Thus, most codon frame-shifts are harmful. During the translation, codons starting with
start codon “ATG” are translated into amino acids until one of the stop codons “TAG”,
“TGA” or “TAA” is reached. Start codons are translated into the protein, but stop codons
only serve to abort the translation, and are not translated.
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1.2 Homologous Gene Finding
Before we define homologous genes and the homologous gene finding problem, we have to
introduce similarity between two sequences. Generally, we use the scores of pairwise sequence
alignments to measure the similarity between two sequences. An alignment between two
sequences describes how one sequence can be edited to the other one through insertions,
deletions (indels) and point mutations. We give positive scores to matches, and negative
scores to indels and mutations. The score of an alignment is the total score of the matches,
indels and mutations in the alignment, and the optimal alignment is the one with maximum
score. There are mainly two types of alignments: global and local. A global alignment
describes the global relationships between two whole sequences, while a local alignments
describes the local relationships between subregions of two sequences.
Two genes are homologous if they share a common evolutionary ancestry. There are two
types of homology: orthology or paralogy. If this homology is a result of a speciation event
(one species diverges into two species), we call the two genes orthologous. If this homology is
a result of a duplication event, we call the two genes paralogous. Unfortunately, it is hard to
define homology using only sequences, without knowing complete evolutionary histories. In
bioinformatics, we often presume that two genes are homologous if they have highly similar
sequences.
Finding homologous genes is essential for biologists. Since homologous genes are likely
to have similar functions, finding homologous genes can help biologists to annotate gene
functions. In this thesis, we explore the homologous gene finding problem:
Definition 1 Homologous Gene Finding Problem: We are given a query gene, more
precisely the query genomic sequence and the annotation of all CDSs of the query gene. We
are also given a DNA sequence of the target genomic sequence. We presume that two genes
are homologous, if and only if the protein sequences encoded by the query and target genes
are highly similar (alignment score above some threshold). We define a target gene as a gene
in the target genomic sequence that is homologous to the query gene. The task of homologous
gene finding is to find all target genes in the target genomic sequence.
To measure the accuracy of the homologous gene finding algorithms, we use statistical
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measures of sensitivity and specificity, which have been widely used to measure the accuracy
of gene finding algorithms [10, 14, 16]. Sensitivity and specificity are defined as follows:
Definition 2 Sensitivity and Specificity: Let TP be the number of true positives (true
predicted as true), FP be the number of false positives (false predicted as true), and FN be
the number of false negatives (true predicted as false). Then, sensitivity, SN , is computed
as SN = TP
TP+FN
, and specificity, SP , is computed as SP = TP
TP+FP
.
On the nucleotide level, sensitivity is the percentage of correctly predicted coding nu-
cleotides over true coding nucleotides; specificity is the percentage of correctly predicted
coding nucleotides over predicted coding nucleotides. On the exon or the gene level, sensi-
tivity is the percentage of predicted exons or genes over true exons or genes; specificity is the
percentage of correctly predicted exons or genes over predicted exons or genes, respectively.
An exon is predicted correctly, if and only if both the start and end of the exon are predicted
correctly. A gene is predicted correctly, if and only if all exons of the gene are predicted
correctly.
1.3 Related Work
Homologous gene finding includes several areas of sequence analysis: the homology search
problem, the gene mapping and alignment problem, and the gene finding problem. These
problems have been well studied in bioinformatics, and there are many existing algorithms
available to solve them. In this section, we briefly review each of these related problems,
and discuss their differences to the homologous gene finding problem.
1.3.1 Homology Search
The homology search problem is to predict homologous regions between two or more se-
quences. In fact, the homology search problem can be simplified as finding local alignments
with high alignment scores. If two regions have a high similarity, the probability that they
are unrelated is low. Thus, we presume that they are homologous, and we call each pair of
highly similar sequences a High-scored Sequence Pair (HSP).
7
The homology search problem is traditionally solved by finding the optimal HSPs using
the Smith-Waterman algorithm [33], which is a dynamic programming algorithm that finds
the best local alignments. The main advantage of the Smith-Waterman algorithm is its
high sensitivity because all similar regions will be uncovered. The main disadvantage of the
Smith-Waterman algorithm is its runtime and memory consumption. If we would like to find
homologous regions between two sequences of sizes m and n, the Smith-Waterman algorithm
requires θ(mn) time and θ(min(m,n)) space. This is often not practical because m and n
can be as large as 1010. Therefore, the Smith-Waterman algorithm is only used when high
sensitivity is critical and query sequences are short.
The first fast homology search software package FASTA [21] was introduced by Lipman
and Pearson in 1985. The idea of FASTA is to firstly find short exact matches of a given
length between query sequences, and then run a Smith-Waterman-like algorithm on regions
containing high density cluster of such matches. In the worst case, the algorithms may take
time θ(mn). In practice, the number of such matches may not be too many, and FASTA is
efficient.
Basic Local Alignment Search Tool (BLAST) [2] is one of the most popular sequence
analysis tools available in the public domain. It was introduced by Altschul and others in
1990. Later, a variety of implementations, and extensions of the BLAST family [2, 3, 41,
40, 25] have been implemented. BLAST uses contiguous matches as seeds and extends each
seed in both directions to form an HSP. Similar to FASTA, BLAST has a tradeoff between
the sensitivity and the speed. Users can specify the seed length to balance the sensitivity
and the speed.
While both FASTA and BLAST trade the sensitivity for the speed, PatternHunter [22,
20, 18] achieves higher sensitivity without slowing down the runtime much. Instead of using
contiguous matches as seeds, PatternHunter uses discontiguous matches, called spaced seeds.
Similar to BLAST, PatternHunter extends each seed in both directions to form an optimal
HSP. Spaced seeds increase the sensitivity of homology search significantly without slowing
down the runtime too much. Moreover, we can train a seed for a particular task, and use
several spaced seeds to increase the sensitivity [20].
Existing homology search tools can not be used to solve the homologous gene finding
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problem directly for several reasons. First, predicted homologous region boundaries found
by sequence alignment software are most likely incorrect splice sites, because homology search
tools always try to extend exons a few nucleotides to achieve better alignment scores. Second,
the homology search tools may not be able to find micro-exons (short exons with length of
up to 25 nucleotides) [36], inserted exons, deleted exons or highly mutated exons. Finally,
the homology search tools cannot distinguish true exons from duplicated partial exons, and
the same thing with genes. In this thesis, the above mentioned issues are considered when
designing the homologous gene finding algorithm.
1.3.2 Gene Mapping and Alignment
Given a spliced mRNA sequence of a gene and a genomic sequence containing exactly that
gene, the gene mapping and alignment problem is to map and align the mRNA sequence
to exons of the gene in the genomic sequence. Some popular gene mapping and alignment
tools include sim4 [12], Spidey [38], BLAT [17] and GMAP [39]. The algorithms of these
gene mapping and alignment tools can be divided into following steps:
1. Locate a target region: An alignment algorithm or a hash table is used firstly to
find all HSPs [12, 38] or k -mer hits (k contiguous matches) [17, 39] between the mRNA
sequence and the genomic sequence. If a region in the genomic sequence contains a
high density of HSPs or k -mer hits, it is very likely that the gene or a close homolog
is located in that region. Thus, a single region is chosen to find approximate exons in
the next step.
2. Find approximate exons: In this step, approximate exons (may not have correct
splice sites) are found using HSPs or clustering k-mer hits from the previous step. This
simple approach usually works well because the mRNA sequence is nearly identical
(better than 95% identical [17]) to exons in the genomic sequence.
3. Adjust splice sites: Splice site signals are used to find correct splice sites with
the constrant that adjacent exons have to follow each other precisely in the mRNA
sequence. If there is a gap between two adjacent approximate exons in the mRNA
sequence, splice sites are adjusted by either greedy or alignment algorithms. Generally,
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greedy algorithms [12, 38] try to extend exons toward each other until they overlap,
and then adjust splice sites in the overlapped region. On the other hand, alignment
algorithms use either seed based algorithms [17] or dynamic programming algorithms
[39] to fill the gap by finding short missed exons between adjacent approximate exons
in the genomic sequence.
The gene mapping and alignment tools work well as long as the mRNA and the genomic
sequence are from the same species. Although these tools support cross species mode, the
accuracy drops significantly even for close species. This is mainly because the assumption
that the mRNA sequence is nearly identical to the exons in the genomic sequence no longer
holds. It has been reported that if sequence identity is lower than 90% [17], the gene
mapping and alignment tools have poor accuracy. Obviously, a lot of homologous gene pairs
have sequence identities lower than 90%. Moreover, the gene mapping and alignment tools
do not look for inserted exons. Therefore, gene mapping and alignment tools are not suitable
to solve the homologous gene finding problem.
1.3.3 Gene Finding
Given one or more genomic sequences, the gene finding problem is to find all genes in the
genomic sequences. During the past ten years of study of the gene finding problem, many
algorithms have been introduced. Among the most successful algorithms are the ones based
on hidden Markov models (HMM). In this section, we focus on HMM-based gene finding
algorithms, and briefly introduce the basic idea of them. Finally, we discuss differences
between the gene finding problem and the homologous gene finding problem.
1.3.3.1 Hidden Markov Models
A hidden Markov model (HMM) is a generative probabilistic model for modeling sequences,
such as DNA sequences. An HMM is a combination of states and transitions. Each state has
its own initial probabilities, transition probabilities, and emission probabilities. An initial
probability of a state is the probability that the state is used as the initial state. An transition
probability of a state is the probability that the current state of the HMM transits from the
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state to itself or another state. An emission probability of a state is the probability that a
symbol is emitted by the state.
A sequence is emitted by emitting symbols one by one from a sequence of states, called
state path. Initially, the current state of the HMM starts from an initial state. Every time
after the current state emits a symbol, the current state transits to the next state. The
current state keeps emitting a symbol and transiting to the next state until a final state
is reached. Then, the sequence of the current states forms a state path, and a sequence is
emitted by the state path. The probability that the sequence is emitted by the state path
is computed as the product of the emission probabilities and the transition probabilities in
the state path.
Hidden Markov models have been widely used in the gene finding problem. We use states
to represent structural properties of genes, such as exons, introns or intergenic regions. Each
state may emit a nucleotide from {A,C,G, T}. We use transitions to represent structural
property changes. Thus, each state path emitting a genomic sequence represents a gene
structures of the genomic sequence.
Each state has a table of the initial probabilities, the transition probabilities, and the
emission probabilities. We define Pi(s) as the initial probability that state s is used as the
initial state, and set Pi(s) = 0 if state s cannot be used as the initial state. We define
Pt(s, s
′) as the transition probability that the current state transits from state s to state s′
directly, and set Pt(s, s
′) = 0 if the current state cannot transit from state s to s′ directly.
We define Pe(n, s) as the emission probability that nucleotide n is emitted by state s, and
set Pe(n, s) = 0 if nucleotide n cannot be emitted by state s.
Figure 1.6 shows a simple HMM modeling a DNA sequence with a single gene. The circles
represent states, and the arrows represent transitions. The red state represents exons, the
green state represents introns, and the black states represent intergenic regions. In order to
distinguish the two intergenic states, we simply call the black state on the left side the initial
state, and the black state on the right side the final state. The the emission probabilities
of the exon state are shown in the red table; the the emission probabilities of the intron
state are shown in the green table; and the the emission probabilities of intergenic states





















Figure 1.6: Simple HMM for a single gene
probability table, but only one table is shown here. Finally, the probability on each arrow
represents the transition probability.
Figure 1.7 shows an example of a simple state path through the HMM shown in Figure 1.6.
The state path represents a gene structure for the short genomic sequence “CATGTAA”.
It basically shows that “ATG” is a gene with a single exon, and the rest of the genomic
sequence is not translated.
Let G = G1...L be a genomic sequence of length L, and H = H1...L be a state path of
length L. Given genomic sequence G and state path H, we use the following formula to
compute joint probability PHMM(G,H) that G is emitted by H.
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Figure 1.7: Simple state path for the DNA sequence “CATGTAA”.
Given a genomic sequence G, we want to find the optimal state path H that maximizes
the posterior probability P (H|G) = PHMM(G,H)/P (G). Since P (G) is a constant for a
given sequence G, maximizing P (H|G) is equivalent to maximizing PHMM(G,H). Thus, the
idea of HMM-based gene finding is to find the state path with the maximum PHMM(G,H),
and such a state path represents the best candidate gene structure [30].
In this thesis, we focus on finding a unique gene in the genomic sequence. Thus, we use
only the HMMs modeling a single gene, and we simply assume that there is a unique initial
state and a unique final state in the HMM (like the one shown in Figure 1.6). Algorithms
for the HMMs modeling multiple genes with multiple initial and final states can be derived
similarly.
1.3.3.2 Higher-Order HMMs
The HMM shown in Figure 1.6 assumes that the emission probabilities are independent from
previously emitted nucleotides. This assumption is obviously false. Exons are made up of
codons of triples of nucleotides, and nucleotides within each codon are strongly dependent.
There are also dependencies between neighboring codons. Therefore, conditional probabil-
ities are used to emit the emission probabilities of higher-order HMMs. If the emission
probabilities of state s depend on the previous Ns nucleotides, where Ns ≥ 0, we say that
state s has order Ns. Different states of the same higher order HMM many have different
orders. Let G be the genomic sequence. We define Pe(Gi, s|Gi−Ns...i−1) to be the emission































Figure 1.8: Higher-order HMM for a single gene, whose exon state has order 1.
nucleotides are Gi−Ns...i−1. Using higher-order HMMs, we compute PHMM(G,H) as follows:






Pe(Gi, Hi|Gi−NHi ...i−1), (1.2)
where we deal with i < NHi sensibly.
Figure 1.8 shows an example of a higher-order HMM. The major differences between it
and the simple HMM in Figure 1.6 are the emission probability tables. In order to make
things simple, only the emission probability table assigned to the exon state is shown, and
the exon state has order 1.
Using a higher-order HMM improves the sensitivity and specificity of gene finding. How-
ever, using a very high order increases the number of the emission probabilities of the state.
This may cause overfitting due to the limited training resources. Thus, we should choose the
order of HMM states carefully based on our training resources.
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1.3.3.3 HMM Training
After we build an HMM topology and choose the initial probabilities based on our under-
standing of gene structures, we need to estimate the emission and the transition probabilities.
This process is called HMM training.
The simplest HMM training method is the maximum likelihood estimation method to
compute the frequency of each transition and emission in a training data set. This method
works only if we have enough genes with complete reference sequences and CDS annotations,
and there is a one-to-one correspondence between an annotation and a state path. Let T (x, y)
be the number of transitions from state x to state y observed in the training data set, and
E(n, s) be the number of emissions of nucleotide n at state s observed in training data set.













Ideally, we would have enough training resource, and the trained HMM probabilities
would be very close to the true values. However, this is sometimes not the case, and over-
fitting occurs. Overfitting causes good performance on the training data, but worse perfor-
mance on unseen data. In order to avoid overfitting, we use a pseudocount C > 0, when
computing the transition and emission probabilities:
Pt(x, y) =
T (x, y) + C
∑
i∈S
(T (x, i) + C)
, (1.5)
Pe(n, s) =
E(n, s) + C
∑
j∈{A,C,G,T}




In the previous sections, we described how to build and train an HMM. Here, we review the
Viterbi algorithm that finds the optimal state path that emits a genomic sequence with the
highest probability. The algorithm uses dynamic programming: we remember the optimal
state path ending at each state emitting each prefix of the genomic sequence.
Let G be the genomic sequence, and L be the length of G. Let S be the set of all states
in the HMM, and K be the number of states in S. Let S1 be the initial state, and SK be
the final state. Let PDP (n, s) be the highest probability of a state path that emits the prefix
G1...n, and emits Gn in state s. Then, it is easy to compute PDP (n, s) as follows:








1, if n = 1 and s = S1,
0, if n = 1 and s 6= S1,
Pe(Gn, s) · maxi∈S(PDP (n − 1, i) · Pt(i, s)), if n > 1.
(1.7)
The order of computation of the Viterbi algorithm is from n = 1 to n = L. The optimal state
path is constructed by tracing back pointers from PDP (GL, SK) to PDP (G1, S1). Since we
need to compute θ(LK) probabilities, and we require θ(K) time to compute each probability,
the runtime complexity of the Viterbi algorithm is θ(LK2).
1.3.3.5 HMM-based Gene Finding Algorithms
We can divide HMM-based gene finding algorithms into three categories: single-genome gene
finding algorithms, dual-genome gene finding algorithms, and multi-genome gene finding
algorithms.
Single-genome gene finding algorithms require only a genomic sequence and training data
as input, and then find genes using an approach similar to the one introduced in this Chapter.
Two popular algorithms are GENSCAN [9] and AUGUSTUS [34].
Dual-genome gene finding algorithms are based on the assumption that protein coding
regions should be better conserved than non-coding regions. In addition to the training
data, they requires two genomic sequences of pairwise alignments between the two genomic
sequences as input. DOUBLESCAN [23] and SLAM [1, 28] use pair-HMMs, which emit
pairwise alignments instead of sequences, to find and align genes in both genomes at the
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same time. TWINSCAN [19, 11] and SGP2 [29] model pre-processed pairwise alignment
information into HMM probabilities to find genes in one or both genomes at the same time.
Multi-genome gene finding algorithms are the newest algorithms in the gene finding prob-
lem. EXONIPHY [31] and N-SCAN (TWINSCAN 3.0) [13] use pre-processed multi-genome
alignments to improve the accuracy of gene finding. They build evolutionary information
into an HMM as a phylogenic hidden Markov model (phylo-HMMs). ExonHunter [6] uses dif-
ferent kinds of sequences as evidence to improve the accuracy of gene finding. This evidence
includes ESTs, cDNAs and proteins from other species.
Existing gene finding tools are not suitable to solve the homologous gene finding problem
because they will find all genes instead of only the homologous genes in the genomic sequence.
Filtering the homologous genes after finding all genes is computationally intensive, and thus
not a good idea. Moreover, gene finding tools do not use the query gene information as much
as our homologous gene finding algorithm, and the query gene information helps to improve
the accuracy of homologous gene finding, as demonstrated in Sections 3.5 to 3.10.
1.3.4 Current Homologous Gene Finding Tools
GeneWise [5] and Projector [24] are two pair-HMM-based homologous gene finding tools. In
this section, we briefly summary both of them.
GeneWise [5] takes a protein sequence and a genomic sequence as input. It uses the
protein sequence to guide homologous gene finding in the genomic sequence. GeneWise
combines a protein-DNA alignment pair-HMM and a single-genome gene finding HMM. If
the alignment pair-HMM contains ms states and mt transitions, and the gene finding HMM
contains ns states and nt transitions, the combined model contains msns states and mtnt
transitions. Thus, if the protein-DNA alignment pair-HMM and the single-genome gene
finding HMM are complicated, the combined HMM is very complicated, and very likely
causes overfitting.
Projector [24] accepts a target genomic sequence, an informant genomic sequence, and
CDS annotations of an informant gene in the informant genomic sequence as input. Similar to
pair-HMM-based gene finding tools, Projector uses a pair-HMM to find homologous genes
in the target genomic sequence, and align the two genomic sequences at the same time.
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Different from pair-HMM-based gene finding tools, Projector restricts transitions to satisfy
the CDS annotations of the informant gene. Since Projector requires a training data set
of homologous genes with complete reference sequences and CDS annotations between the




In this chapter, we introduce a new algorithm to solve the homologous gene finding problem.
For a given query gene and a target genomic sequence, the goal is to find all genes (also
called target genes) that are homologous to the query gene in the target genomic sequence.
We borrow the idea of gene mapping and finding algorithms, and use a homology search
algorithm and a gene finding algorithm in our homologous search. We divide our homologous
gene finding algorithm into four steps.
1. Finding HSPs: In this step, we find HSPs between the query gene and the target
genomic sequence using a seed-based homology search algorithm. We also filter out
the HSPs with low alignment scores to locate accurate target regions in the next step.
2. Locating Target Regions: Using the HSPs found in the previous step, we locate
regions of the target genomic sequence that we believe contain a target gene. These
regions are called target regions. By locating the target regions before finding gene
candidates, both the accuracy and speed of homologous gene finding are improved.
3. Finding Gene Candidates: For each target region, we predict several gene can-
didates that are homologous to the query gene. We use an HMM-based gene finding
algorithm that is modified for this task. Using HMM-based gene finding, we can recover
micro-exons that cannot be recovered by homology search algorithms.
4. Assessment of Gene Candidates: Finally, we rank the candidates from the previous
step by aligning them to the query gene using global protein alignment.
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We explain the details of each step in the following sections.
2.1 Finding HSPs
The first step of our homologous gene finding algorithm is to find the HSPs between the
query gene and the target genomic sequence. We adopt a seed-based homology search
algorithm, as described in Section 1.3.1. The difference between our HSP finding and general
homology search is that we are interested in only the HSPs located in the coding regions of
the target genomic sequence. Therefore, we need to choose the homology search algorithm
that performs well in the coding regions.
Homologous genes do not necessarily contain highly similar CDSs. This is because mul-
tiple codons can be translated to the same amino acid, as indicated in Section 1.1. Thus,
translated proteins may be very similar, even if they originate from very different CDSs. This
raises a problem that homologous regions may not contain contiguous matches, which are
used as seeds by some homology search algorithms, such as BLAST family [2, 3, 41, 40, 25].
There are two approaches described below to solve the problem:
1. Spaced seed models, designed especially for coding sequences, and multiple spaced seed
models can be employed to improve the sensitivity. This approach was studied in work
on optimal spaced seeds [7] and PatternHunter [20].
2. The protein sequence, encoded by the query gene, and the target genomic sequence
can be aligned. The problem of finding the HSPs between a protein sequence and a
nucleotide sequence was studied in tBLASTx [25, 40] and tPatternHunter [18].
Comparing the above two approaches, the multiple spaced seed approach performs faster
with an acceptable good sensitivity, while the protein-nucleotide alignment approach per-
forms slower with a better sensitivity. In our work, we choose the protein-nucleotide align-
ment approach mainly for two reasons. First, finding the HSPs with a high sensitivity is
critical for locating the accurate target regions in the next step. Second, the bottleneck of
the homologous gene finding is the HMM-based gene finding step, and the running time used
for the homology search is not a limiting factor. The protein-nucleotide alignment approach
is examined in Section 3.3.
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Even though we choose to use the protein-nucleotide alignment approach, the multiple
spaced seed approach can be adopted easily when speed is critical. In order to avoid harmful
codon frame-shifts, as described in Section 1.1, we do not allow gaps in the HSPs. Disallowing
gaps can also speed up the homology search algorithm.
We observed regions of the target genomic sequence that contains many HSPs with
low alignment scores. These HSPs are likely emitted by a combination of duplications,
mutations and indels during evolution. For example, a complete gene or a part of a gene was
first duplicated, and then a lot of mutations, and indels happened in the duplicated region.
As a result, we find many HSPs with low alignment scores in the region, but there is no
functional gene in the region. We are not interested in these regions, and these regions are
not desirable in the next step. In order to locate accurate target regions, we filter out the
HSPs with alignment scores lower than a threshold.
We choose the threshold carefully so that most of the noise is filtered out, and most of
the useful information is retained. Let TPin be the number of true positives retained, and
TPout be the number of true positives filtered out after filtering. Let FPin be the number of
false positives retained, and FPout be the number of false positives filtered out after filtering.
Here, an HSP is a true positive if it hits a homologous region, and an HSP is false positive







In this equation, FPout
FPin+FPout
is the percentage of noise filtered out, and TPin
TPin+TPout
is the
percentage of useful information retained. We maximize the sum of the percentage of noise
filtered out and the percentage of useful information retained.
There are two advantages of filtering HSPs in this way. First, while most of the noise is
filtered out, and most of the useful information is retained, we likely increases the weight of
useful information, as well as the accuracy to locate target regions. Second, by keeping most
of the useful information, we keep the option to use this information in the gene finding step.
However, we currently do not use this information in the gene finding step, and we will use
it in the future. The effects of filtering the HSPs are discussed in Section 3.4.
In summary, we translate the query gene to a protein sequence, and find high scoring
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HSPs without gaps between the protein sequence and the target genomic sequence. These
HSPs are used in the next step to locate the target regions.
2.2 Locating Target Regions
A target region is a region of the target genomic sequence that is likely to contain a target
gene. Ideally, we should find several HSPs in the true target region that contains a target
gene, because there should be homologous regions between the query gene and the target
gene. Thus, we locate target regions by finding the HSP clusters with high total alignment
scores. This approach works well as long as we find enough HSPs in the true target region.
To locate target regions, we cluster the HSPs using the nearest neighbor clustering al-
gorithm. Two HSPs belong to the same cluster, if and only if they are both located on
the same strand of the target genomic sequence, and their distance is smaller than a given
threshold. To choose a reasonable threshold, we download annotations of known genes from
UCSC Genome Bioinformatics Site [35], and study the lengths of the 2051 known genes on
human chromosome 6. We set the threshold as 650, 000, which is approximately half of the
length of the longest known gene (with gene ID NM 013988 [35]) on human chromosome
6. Then, we compute the score of each HSP cluster as the sum of the alignment scores of
individual HSPs within the cluster. If a HSP cluster scores highly, it is likely that there is a
target gene in that region. Thus, we pick several highest scoring clusters to locate the target
regions. We study several variants of this method in Section 3.5.
We can only use HSP clusters to estimate the approximate location of the target region.
It is difficult to estimate where the target region starts and ends, especially if the 5′ or
3′ ends of the query gene and a target gene are not homologous. This is possible if the
function of these proteins is determined by the middle of the query gene and that of a target
gene, and the other regions are not conserved. The most obvious solution is to define a big
enough constant for the target region size. However, finding a short gene in a large region is
obviously slower than in a region of approximately correct size. Such a search also adds too
much noise that causes poor gene finding results. Therefore, we describe the target region
by a nucleotide near the middle of the target region, and the flexible ranges of the target
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Figure 2.1: Initiator and its associated 5’ and 3’ CDS lengths
Initiator: Initiator I0 is a nucleotide in the target genomic sequence which is likely to be
located within an exon. The initiator is chosen as the middle nucleotide of the highest
scoring HSP in the target region, as shown in Figure 2.1. We can also predict in
which codon frame the initiator lies. The frame should match the codon frame of
the nucleotide, to which the initiator is aligned, in the query gene. We will use this
information later to determine where to start HMM dynamic programming (the base
case).
5′ CDS Length: The 5′ CDS length λ5′ , associated with I0, is the expected number of
coding nucleotides on the 5′ side of I0. We compute λ5′ as the number of coding
nucleotides on the 5′ side of I0 in the query gene, as shown in Figure 2.1. We will use
it later to determine when to stop our enhanced Viterbi algorithm in the 5′ direction.
3′ CDS Length: The 3′ CDS length λ3′ , associated with I0, is the expected number of
coding nucleotides on the 3′ side of I0. We compute λ3′ as the number of coding
nucleotides on the 3′ side of I0 in the query gene, as shown in Figure 2.1. Similarly, we
will use this information to determine when to stop our enhanced Viterbi algorithm in
the 3′ direction.
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The idea behind the use of I0, λ5′ and λ3′ to describe a target genomic sequence is based
on the observation that the CDS lengths generally do not change much, as demonstrated
in Section 3.9. We also observed that the gene lengths can change significantly during the
evolution of homologous genes, as demonstrated in Section 3.9.
There is no guarantee that the highest scoring HSP always overlaps an exon of the target
gene, and thus we might choose an incorrect initiator from the highest scoring HSP. To avoid
this problem, we choose several initiators from several highest scoring HSPs for each target
region. We study several variants of this method in Section 3.6.
In summary, we first locate target regions by clustering the HSPs, and then choose several
initiators with their associated 5′ and 3′ CDS lengths for each target region. Locating the
target regions before gene finding can improve both the accuracy and speed of homologous
gene finding. Both the accuracy and the speed are improved because those noise regions,
which we are not interested in, are filtered out before the gene finding step.
2.3 Finding Homologous Gene Candidates
In this step, we find a candidate gene structure for each initiator and its associated 5′ and
3′ CDS lengths. We later evaluate these gene candidates and select several target genes. To
find candidate gene structures, we introduce a new HMM-based gene finding algorithm, and
enhance previous HMM-based gene finding algorithms as follows:
Biased Training: We train an HMM to be biased toward the query gene to improve the
accuracy of the homologous gene finding.
Enhanced Viterbi Algorithm: We modify the Viterbi algorithm to be able to find gene
structures starting from the initiator, and progressing in both the 5′ and 3′ directions.
CDS Length Penalty: We introduce the new CDS length penalty as a measure of how
the CDS lengths of the query gene and its homologous gene vary. We also combine the
HMM state path probability and the CDS length penalty to define a new gene scoring
system to further improve the accuracy of the homologous gene finding.
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Stopping Condition: Using the new CDS length penalty and the new scoring system, we
stop the enhanced Viterbi algorithm when a stopping condition is reached. The new
stopping condition improves the speed of homologous gene finding without harming
the accuracy.
In Section 2.3.1, we explain the HMM used to predict gene candidates. From Section 2.3.2
to Section 2.3.6, we explain the details of above mentioned enhancements.
2.3.1 Hidden Markov Model for Homologous Gene Finding
We use the HMM in Figure 2.2 to find candidate gene structures. In the figure, circles rep-
resent HMM states; triangles represent signal submodels; and arrows represent transitions.
State S is the silent initial state, and state F is the silent final state. The red states represent
exons, and the green states represent introns. The exon and intron states are of the 4th order.
The left triangle represents the start signal submodel, and the right triangle represents the
stop signal submodel. The orange triangles represent the donor signal submodels, and the
pink triangles represent the acceptor signal submodels. The HMM in Figure 2.2 is a single
gene submodel that does not have any states representing either UTR or intergenic regions.
The overall performance of this HMM for homologous gene finding is studied in Section 3.8.
The start and stop signal submodels are depicted in Figure 2.3 by notations similar to
those in Figure 2.2. In addition, the black states represent the regions before the start codon
or after the stop codon. The states, which show a single symbol inside, can emit only the
nucleotide symbolized by that symbol. Compared to the states in Figure 2.2, there is less
data to train the emission probabilities of the states in the start and stop signal submodels.
This occurs because the number of nucleotides that can be used to train a signal state is
approximately the same as the number of exons, whereas the number of nucleotides that can
be used to train an exon or an intron state is approximately the total length of the exons or
introns, respectively. For this reason, we use states of the 2nd order for the start and stop
signal submodels to avoid overfitting.
The donor and acceptor signal submodels are shown in Figure 2.4 by notations similar
to those in Figure 2.3. Similarly as in the case of the start and stop signal submodels, we
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Figure 2.2: HMM used for homologous gene finding: State S is the silent initial state, and
state F is the silent final state. The red states are the exon states, and the green states are
intron states. The left triangle is the start signal submodel, and the right triangle is the
stop signal submodel. The orange triangles are the donor signal submodels, and the pink









Figure 2.3: Start/stop signal submodels: The red states are the exon states, and the black
states are intergenic/UTR states. The states, which show a single symbol inside, can emit








Figure 2.4: Donor/acceptor signal submodels: The red states are the exon states, and the
green states are intron states. The states, which show a single symbol inside, can emit only
the nucleotide symbolized by that symbol.
use states of order 2 in the donor and acceptor signal submodels.
2.3.2 Biased Training
Each gene has its own structural properties, such as distribution of nucleotides in the CDS.
There is a good chance that many of these properties are conserved for homologous genes
during evolution, as studied in Section 3.7. Based on this assumption, we use the query gene
to train an HMM to be biased toward the query gene.
Let Pt(x, y) be the transition probability from state x to state y, and Pe(n, s) be the
emission probability that nucleotide n is emitted by state s. Let T (x, y) be the number of
transitions from state x to state y observed in the training data set for the target species,
and T ′(x, y) be the number of transitions from state x to state y observed in the query gene.
Similarly, let E(n, s) be the number of nucleotides n emitted by state s observed in training
data set for the target species, and E ′(n, s) be the number of nucleotides n emitted by the
state s observed in the query gene. Let M be the number of genes in the training data set,
and Z be a weight. Let S be the set of all states in the HMM, and C be the pseudocount.
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We set HMM probabilities as follows:
Pt(x, y) =
T (x, y) + Z · T ′(x, y) + C
∑
i∈S
(T (x, i) + Z · T ′(x, i) + C)
, (2.2)
Pe(n, s) =
E(n, s) + Z · E ′(n, s) + C
∑
j∈{A,C,G,T}
(E(j, s) + Z · E ′(j, s) + C)
. (2.3)
Intuitively, the biased training with above formulas is equivalent to training on a virtual
training data set of M genes from the training data set and Z copies of the query gene. In
this virtual training data set, the query gene weights Z
M+Z
. To keep the query gene weight







in the virtual training data set.
We use weight W to adjust how much the HMM is biased toward the query gene. If W
is too big, we have overfitting, because the HMM probabilities are biased too much. If W
is too small, the sensitivity is not improved much, because the HMM probabilities are not
biased much. Therefore, we carefully choose W based on the distance between the query and
the target species to avoid overfitting, and to maximize the sensitivity of the homologous
gene finding, as studied in Section 3.8.
The idea of biased training is simple, but it improves the sensitivity of homologous
gene finding significantly when the homologous genes are conserved, as shown in Section
3.8. Biased training builds the query gene information into the HMM without increasing the
complexity of the model, and thus it does not slow down the gene finding algorithm. However,
not all HMM probabilities should be biased. In our experiments described in Section 3.7, we
observed that the transition probabilities may not be conserved. In addition, the emission
probabilities of the intron states are not as well conserved as the emission probabilities of
the exon states. For now, we bias only the emission probabilities of the exon states and
signal states. In fact, our study on biased training is not complete. We are still looking for
the most efficient way to train an HMM to be biased toward the query gene, and our future
work in this area is described in Section 4.2.
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2.3.3 Enhanced Viterbi Algorithm
We have already described how the Viterbi algorithm finds the optimal HMM state path
that represents the best gene structure in Section 1.3.3.4. Here, we assume that there is a
unique gene in the genomic sequence, and there is a unique initial state and a unique final
state in the HMM. Let G be the genomic sequence, and L be the length of G. Let S be the
set of all states in the HMM, and K be the number of states in S. Without loss of generality,
we can say that S1 is the initial state, and SK is the final state. Let PDP (n, s) be the highest
probability of a state path that emits the prefix G1...n, and emits Gn in state s. The Viterbi
algorithm computes PDP (n, s) from n = 1 to n = L, and the probability that G is emitted
by the optimal state path is PDP (L, SK). The optimal state path can be constructed by
tracing the back pointers from PDP (L, SK) to PDP (1, S1). For our HMM (Figure 2.2), the
Viterbi algorithm ideally starts a few nucleotides before the start codon, and finishes a few
nucleotides after the stop codon. However, finding the start and stop codons is the most
challenging part of finding candidate gene structures. Therefore, we cannot apply the Viterbi
algorithm directly.
Recall that we describe the target region by a nucleotide (I0) near the middle of the
target region, and flexible ranges (λ5′ and λ3′) of the target region on the 5
′ and 3′ ends.
Here, we introduce a new dynamic programming algorithm that starts from the initiator,
and proceeds in both directions. Without loss of generality, we can say that SI0 is the exon
state representing the codon frame of the initiator I0. If n < I0, let PDP ′(n, s) be the highest
probability of a state path that emits the genomic sequence Gn...I0 , and emits Gn in state s.
If n > I0, let PDP ′(n, s) be the highest probability of a state path that emits the genomic
sequence GI0...n, and emits Gn in state s. The enhanced Viterbi algorithm uses the following
recurrence:
















1, if n = I0 and s = SI0 ,
0, if n = I0 and s 6= SI0 ,
Pe(Gn, s) · max
i∈S
(PDP ′(n − 1, i) · Pt(i, s)), if n > I0,
Pe(Gn, s) · max
i∈S
(PDP ′(n + 1, i) · Pt(s, i)), if n < I0.
(2.4)
The enhanced Viterbi algorithm computes PDP ′(n, s) from n = I0 to n = 1, and from
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n = I0 to n = L. For convenience, if n < I0, we can say that HDP ′(n, s) is the optimal
state path that emits Gn in state s, and emits the genomic sequence Gn...I0 with the highest
probability of PDP ′(n, s). Similarly, if n > I0, we can say that HDP ′(n, s) is the optimal
state path that emits Gn in state s, and emits the genomic sequence Gn...I0 with the highest
probability of PDP ′(n, s). HDP ′(n, s) can be constructed by tracing the back pointers from
PDP ′(n, s) to PDP ′(I0, SI0), but we did not compute HDP ′(n, s) in practice. We introduce
HDP ′(n, s) in order to simplify explanations, and we choose symbol H as the last character
of “patH”. In practice, we construct the optimal state path by concatenating HDP ′(1, S1)
and HDP ′(L, SK). Therefore, we can imagine the enhanced Viterbi algorithm as the Viterbi
algorithm to find the optimal state path subject to the additional constraint that GI0 is
emitted by SI0 . Until now, we have not mentioned when to stop the ehnahced Viterbi
algorithm. We introduce the stopping condition to determine when to stop the enhanced
Viterbi algorithm in Section 2.3.6.
The runtime complexity of the enhanced Viterbi algorithm is θ(LK2). The runtime
complexity remains the same as that of the Viterbi algorithm, as long as there is a unique
state that represents the codon frame of I0, and is not in any signal submodel. If there are
multiple states representing the same codon frame, we have to examine all possible choices of
SI0 to concatenate HDP ′(1, S1) and HDP ′(L, SK) properly. Therefore, the runtime complexity
of the algorithm changes to θ(mLK2), where m is the number of possible choices of SI0 .
2.3.4 CDS Length Penalty
In this section, we introduce the use of the CDS length penalty, together with the enhanced
Viterbi algorithm, to improve both the speed and the sensitivity of the homologous gene
finding. The new CDS length penalty is based on the assumption that the CDS lengths
of homologous genes are conserved during evolution. This assumption is supported by our
study of the CDS lengths of homologous genes in Section 3.9.
To model the CDS length penalties, we adopt the approach of Christopher Burge in
his program GENSCAN [8]. In his model, it is assumed that only a single codon insertion
or deletion can occur in a generation, and the probabilities per generation of insertion and
deletion are the same. Let n be the number of generations, p be the probability per generation
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of insertion or deletion, and λ′ be the observed exon length. The distribution of the lengths
of homologous exons is approximately normal with mean µ ≈ λ′ and variance σ2 ≈ 2npλ′.
Assuming that n is on the order of 1/p, the variance of the distribution is on the order of λ′. If
we assume that the evolution of each individual exon is independent of those of other exons,
the distribution of the CDS lengths of homologous genes is also approximately normal. This
is because the CDS length is the sum of the exon lengths, which are independent normally
distributed variables, and the sum of independent normally distributed random variables is
normal.
Recall that λ5′ is the expected number of coding nucleotides on the 5
′ side of the initiator
I0. Let λ̂5′ be the number of coding nucleotides on the 5
′ side of the initiator I0 of a
gene candidate found. Based on the result of Christopher Burge [8], we approximate the
distribution of λ̂5′ with a normal distribution with mean µ ≈ λ5′ and variance σ2 ≈ 2λ5′ .
Thus, we define the CDS length penalty PCDS(λ̂5′ , λ5′) for the 5
′ end to be the probability
density of CDS length λ̂5′ being observed as follows:


















We can similarly derive the CDS length penalty PCDS(λ̂3′ , λ3′) for the 3
′ end. The study on
our model is not complete, but in this thesis, we present some insights of this approach first.
We will still improve improve the approach, as described in Section 4.2.
2.3.5 Scoring System
The single-gene HMM in Figure 2.2, with silent initial and final states, favors shorter gene
structures. This is because we use Equation (1.2) to compute joint probability PHMM(G,H)
that genomic sequence G is emitted by state path H, and shorter gene structures have fewer
terms in Equation (1.2). We solve the problem by normalizing the probability that genomic









where π(G) is the set of all state paths that can emit G. We compute
∑
i∈π(G) PHMM(G, i)
with the enhanced forward algorithm, which is just the enhanced Viterbi algorithm with
“max” replaced by “
∑
” in Equation (2.5). Since the runtime complexities to find the maxi-
mum and to compute the sum are the same, the runtime complexity of the enhanced forward
algorithm is the same as that of the enhanced Viterbi algorithm. Thus, the runtime complex-
ity to find the optimal state path that maximizes the normalized probability P ′HMM(G,H)
is θ(LK2).
For i < I0, recall that HDP ′(i, S1) is the optimal state path that emits Gi in state S1, emits
GI0 in state SI0 , and emits genomic sequence Gi...I0 with the highest probability of PDP ′(i, S1).
Without loss of generality, we can say that Hi = HDP ′(i, S1) for i < I0. Similarly, we can say
that Hj = HDP ′(j, SK) for j > I0. Let λ(H) be the number of coding nucleotides in the gene
structure represented by state path H. Let Hi,j = Hi + Hj be the state path constructed by
concatenating Hi and Hj. Recall that the CDS length penalty is the probability density of
a particular CDS length being observed. We combine the normalized HMM probability and
the CDS length penalty as our final probability of a gene structure as follows:
P ∗(Gi...I0 , Hi) = P
′
HMM(Gi...I0 , Hi) · PCDS(λ(Hi), λ5′), (2.7)
P ∗(GI0...j, Hj) = P
′
HMM(GI0...j, Hj) · PCDS(λ(Hj), λ3′), (2.8)
P ∗(Gi...j, Hi,j) = P
∗(Gi...I0 , Hi) · P ∗(GI0...j, Hj). (2.9)
We did not find any algorithm that is capable of finding the state path maximizing
Equation (2.9) directly. Instead, we use dynamic programming to compute P ′HMM(Gi...I0 , Hi)
for i ∈ [1...I0), and then find Hi∗ such that
(Gi∗...I0 , Hi∗) = arg max
i∈[1...I0)
P ∗(Gi...I0 , Hi). (2.10)
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Similarly, we use dynamic programming to compute P ′HMM(GI0...j, Hj) for j ∈ (I0...L], and
then find Hj∗ such that
(GI0...j∗ , Hj∗) = arg max
j∈(I0...L]
P ∗(GI0...j, Hj). (2.11)
Finally, we construct state path Hi∗,j∗ = Hi∗ + Hj∗ by concatenating Hi∗ and Hj∗ , and it is
obvious that
(Gi∗...j∗ , Hi∗,j∗) = arg max
i∈[1...I0),j∈(I0...L]
P ∗(Gi∗...j, Hi + Hj). (2.12)
In practice, we only compute Equation (2.7) for 1 ≤ i′ ≤ i < I0 and Equation (2.8) for
I0 < j ≤ j′ ≤ L to speed up the homologous gene finding without harming the accuracy.
We dynamically choose the values of i′ and j′ by the stopping condition, as introduced in
the next section.
Recall that the runtime complexity to find the optimal state path that maximizes the
normalized probability P ′HMM(Gi...I0 , Hi) is θ(LK
2). In practice, we remember the number of
coding nucleotides in the dynamic programming algorithm, and thus when P ′HMM(Gi...I0 , Hi)
is computed, λ(Hi) is computed. Assuming that P
′
HMM(Gi...I0 , Hi) and λ(Hi) are computed,
and the computation of PCDS(λ(Hi), λ5′) costs constant time, we can compute P
∗(Gi...I0 , Hi)
in constant time. The runtime complexity to compute P ∗(Gi...I0 , Hi) is θ(LK
2) + O(LK2) +
O(1) = O(LK2). Similarly, the runtime complexity to compute P ∗(GI0...j, Hj) is also θ(LK
2).
Therefore, the runtime complexity to compute P ∗(Gi...j, H) is θ(LK
2)+O(LK2) = O(LK2).
In summary, instead of finding the optimal gene structure, we use the dynamic program-
ming algorithm to find several homologous gene candidates, and then use the CDS length
penalty to pick the candidate with the largest P ∗(Gi...j, H) from all candidates found in the
target region.
2.3.6 Stopping Condition of the Enhanced Viterbi Algorithm
Using our CDS length penalties, we stop the dynamic programming when a higher state
path probability can never be achieved. This means that our system dynamically chooses
the target region size. In this section, only the stopping condition on the 5′ end is introduced;
the stopping condition on the 3′ end is derived similarly.
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For i < I0, recall that Hi is the optimal state path that emits Gi in state S1, emits
GI0 in state SI0 , and emits Gn...I0 with the highest probability of PDP ′(i, S1), and λ(Hi) is
the number of coding nucleotides in the gene structure represented by state path Hi. Our
stopping condition is based on two simple observations:
PCDS(λ̂1, λ5′) ≤ PCDS(λ̂2, λ5′), if λ̂1 ≥ λ̂2 > λ5′ , (2.13)
P ∗(Gi...I0 , Hi) ≤ PCDS(λ(Hi), λ5′). (2.14)
Observation (2.13) is true because the probability density function of a normal distri-
bution is decreasing on the right side of the mean, and thus PCDS(λ̂, λ5′) is decreasing
in region (λ5′ , +∞). Observation (2.14) is true because P ′HMM(Gi...I0 , Hi) ≤ 1, and thus
P ∗(Gi...I0 , Hi) = P
′
HMM(Gi...I0 , Hi)PCDS(λ(Hi), λ5′) ≤ PCDS(λ(Hi), λ5′). From these two ob-
servations, we can prove the following claim.
Claim 3 Assume that we have computed P ∗(Gi...I0 , Hi) for i ∈ [i′, I0), and found Hi∗ such
that (Gi∗...I0 , Hi∗) = arg maxi∈[i′...I0) P
∗(Gi...I0 , Hi). If both Equation (2.15) and Equation
(2.16) hold for all state s ∈ S, there is no state path Hi such that i < i′ and P ∗(Gi...I0 , Hi) >
P ∗(Gi∗...I0 , Hi∗).
PCDS(λ(HDP ′(i
′, s)), λ5′) < P
∗(Gi∗...I0 , Hi∗), (2.15)
λ(HDP ′(i
′, s)) > λ5′ . (2.16)
Proof. Let Hi be any state path such that i < i
′. Without loss of generality, we can say
that HDP ′(i
′, s) is a suffix of Hi. Then,
λ(Hi) ≥ λ(HDP ′(i′, s))
> λ5′ (by Equation (2.16))
P ∗(Gi...I0 , Hi) < PCDS(λ(Hi), λ5′) (by Observation (2.14))
≤ PCDS(λ(HDP ′(i′, s)), λ5′) (by Observation (2.13))
< P ∗(Gi∗...I0 , Hi∗) (by Equation (2.15))
Therefore, there is no state path Hi such that i < i
′ and P ∗(Gi...I0 , Hi) > P
∗(Gi∗...I0 , Hi∗).
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Claim 3 indicates that the enhanced Viterbi algorithm should stop on the 5′ end when
both Equation (2.15) and Equation (2.16) hold for all state s ∈ S, and we do not compute
P ∗(Gi...I0 , Hi) for i ∈ [1, i′). We can similarly derive the stopping condition on the 3′ end.
Therefore, with the CDS length penalty and the stopping condition, we speed up the homol-
ogous gene finding without harming the accuracy. Several study cases are demonstrated in
Section 3.10.
There is no guarantee that the stopping condition is always reached. To make sure
that the algorithm always finishes, we add a second stopping condition: the gene length of
homologous gene candidates is at most L′. We set L′ = 1, 400, 000, which is a little longer
than the longest known gene (with gene ID NM 013988 [35]) on human chromosome 6.
2.4 Assessment of Gene Candidates
The ultimate result of the previous step is a list of target gene candidates for each of the
target regions. The purpose of this step is to choose the best candidate as the target gene
in each target region, and then rank these target genes.
Since we define homologous genes as the genes encoding homologous proteins, we assess
each of the target gene candidates using protein alignments. First, we translate target gene
candidates to protein sequences, and align them to the protein translated from the query
gene by the Needleman-Wunsch algorithm [27]. If a candidate is a gene homologous to the
query gene, the protein alignment should have a high alignment score. After we choose the
candidate with the highest protein alignment score in each of the target regions, we rank all
of the candidates by their scores. A performance comparison between our approach of using





We implemented our algorithm to find homologous genes in Java, and then performed several
experiments to validate the algorithm. Our implementation starts from HSPs found by
BLAST [25, 40]. In this chapter, we first introduce the data sets used in our experiments,
and then present the overall performance of our homologous gene finding algorithm, as well
as the assessments of the individual steps of the algorithm.
3.1 Data Sets
In this section, we first describe three data sets that we used: the human genome training
data set, the training data set of homologous genes, and the testing data set of homologous
genes. The human genome training data set contains the reference sequences and the CDS
annotations of 1070 human genes for training the HMM probabilities, as explained in Section
2.3.2. The training data set of homologous genes contains the reference sequences and
the CDS annotations of 200 homologous gene groups for studying the parameters of our
homologous gene finding algorithm. These parameters include the HSP filtering threshold,
the number of target regions per target gene, the number of initiators per target region, and
weight W . The testing data set of homologous genes contains the reference sequences and
the CDS annotations of 400 homologous gene groups for evaluating the performance of our
homologous gene finding algorithm. We also describe the target genomic sequence that we
used in this section.
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Number of Genes 1070
Average Gene Length 6476.75
Average Complete CDS Length 1195.63
Average Number of Exons per Gene 5.31
Table 3.1: Overview of the human genome training data set
3.1.1 Human Genome Training Data Set
The human genome training data set is based on the training data set of gene finder AUGUS-
TUS [34]. The original data set contained 1284 human genes retrieved from NCBI GenBank
in October 2002. We removed 214 genes that did not satisfy various technical requirements:
• At least 20 nucleotides before the start codon in each reference sequence.
• At least 6 nucleotides after the stop codon in each reference sequence.
• At least 7 nucleotides in each exon.
• At least 29 nucleotides in each intron.
• The nucleotides “GT” right after each donor sites.
• The nucleotides “AG” right before each acceptor sites
The basic statistics of the remaining 1070 genes as our human genome training data set
are shown in Table 3.1. We used the human genom training data set to train the HMM
probabilities, as introduced in Section 2.3.2.
3.1.2 Training and Testing Data Sets of Homologous Genes
The training and testing data sets of homologous genes are based on NCBI HomoloGene 49.1
released on April 28, 2006 [26], which is a database of groups of homologous genes of several
completely sequenced eukaryotic genomes. We restricted our data sets to three species: H.
sapiens (human), M. musculus (house mouse) and C. elegans. We followed the following
steps to prepare our training and testing data sets:
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H. sapiens M. musculus C. elegans
Number of Genes 200 200 200
Average Gene Length 33284.57 24780.59 2974.52
Average Complete CDS Length 1337.30 1326.15 1285.89
Average Number of Exons per Gene 10.70 10.43 5.67
Table 3.2: Overview of the training data set of homologous genes
H. sapiens M. musculus C. elegans
Number of Genes 400 400 400
Average Gene Length 36536.54 28120.29 3004.86
Average Complete CDS Length 1337.23 1322.96 1311.36
Average Number of Exons per Gene 10.44 10.36 5.87
Table 3.3: Overview of the testing data set of homologous genes
1. We filtered all homologous gene groups in NCBI HomoloGene, and retained those ones
that contain at least one gene from each of H. sapiens, M. musculus, and C. elegans.
We removed the genes from other than the three species.
2. We used GMAP [39] to map each gene to its genome. After we checked if the mapped
CDS annotation is consistent with the CDS annotation in NCBI GenBank, we removed
the genes that have inconsistent annotations. Here, two annotations were consistent if
and only if they had the same number of exons, and each pair of corresponding exons
had the same length.
3. We randomly selected 200 homologous gene groups as the training data set, and 400
homologous gene groups as the testing data set. The training and testing data sets do
not overlap.
The basic statistics of the training and testing data sets are shown in Tables 3.2 and 3.3,
respectively. Although we expected to see paralogous genes, each homologous gene group
in the training and testing data sets contains only one gene from each of the three species.
Thus, we performed experiments on only orthologous genes for now, and we will perform
more experiments on paralogous genes in the short future.
In all experiments that we performed with our implementation, we used human target
genes, and mouse or C. elegans genes as query genes. Without further notice, we refer the
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training data set as the training data set of homologous genes, and the testing data set as
the testing data set of homologous genes in this chapter. When studying the parameters
of our homologous gene finding algorithm, we used homologous genes in the training data
set. When evaluating the performance of our homologous gene finding algorithm, we used
homologous genes in the testing data set.
3.1.3 Target Genomic Sequence
In all experiments requiring the target genomic sequence, we used the NCBI human genome
36.1 released in March 2006 as the target genomic sequence. We downloaded the complete
reference sequences with a total size of approximately 3.14GB from UCSC genome browser
[35]. Repeats in the genomic sequences were masked by RepeatMasker [32] and Tandem
Repeats Finder [4].
3.2 Overall Performance
Since we do not use an HMM that involves gene structure information as much as the HMMs
used by GeneWise and Projector, it is unfair to compare the accuracy of our homologous
gene finding algorithm to that of GeneWise or Projector. Thus, we evaluated the accuracy
of our homologous gene finding algorithm, and compared the results to TBLASTN [25, 40].
We used Eval [16] to compute the sensitivity and specificity of the homologous gene finding.
To evaluate the overall performance of our homologous gene finding algorithm, we used
the homologous gene groups in the testing data set, and designed experiment as follows:
First, we found HSPs between the protein sequence encoded by the query gene and the
target genomic sequence, and filtered HSPs with a threshold of 55. Second, we located three
target regions for each target gene, and chose three initiators from each target region. Third,
we set W = 0.5, and found a gene candidate for each initiator. Finally, we chose the best
homologous gene from all gene candidates using protein alignment.
To compare the sensitivity and specificity to those of TBLASTN, we found HSPs between
the protein sequence encoded by the query gene and the target genomic sequence. Then, we
filtered HSPs with a threshold of 55, and chose the best target region as the highest scoring
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Gene SN / SP Exon SN / SP Nucleotide SN / SP
M. musculus 33.25% / 33.25% 74.45% / 76.80% 82.29% / 83.51%
C. elegans 0.25% / 0.27% 13.65% / 18.46% 26.03% / 29.98%
Table 3.4: Sensitivity and specificity of our homologous gene finding implementation
Gene SN / SP Exon SN / SP Nucleotide SN / SP
M. musculus 0% / 0% 6.73% / 5.35% 90.67% / 82.92%
C. elegans 0% / 0% 1.27% / 1.75% 49.41% / 77.04%
Table 3.5: Sensitivity and specificity of homologous gene finding using TBLASTN
HSP cluster. Here, we simply used HSPs in the best target region as exons of the target
gene, and HSP boundaries as splice sites.
The experiment results are shown in Tables 3.4 and 3.5. Table 3.4 shows that our ho-
mologous gene finding implementation has good sensitivity and specificity when the query
and target genes are from close species. However, the sensitivity and specificity drops signifi-
cantly when the query and target genes are from distant species. This is because homologous
genes are more likely to be conserved in close species than those in distant species. When
using mouse query genes, and human target genes, our implementation achieves an exon
sensitivity of 74.45% and an exon specificity of 76.80%. Table 3.5 shows that TBLASTN is
not sufficient to find splice sites and gene structures, because the gene level and exon level
sensitivities and specificities are very low. Comparison of Tables 3.4 and 3.5 shows that gene
and exon sensitivities and specificities of our homologous gene finding implementation are
more accurate than that of TBLASTN. We observed that finding homologous genes with
TBLASTN has higher nucleotide sensitivity than our homologous gene finding implementa-
tion. This is because we did not use the alignment information during the process of gene
finding, and we will model the alignment information into the gene finding algorithm.
3.3 Finding HSPs
In this experiment, we compared two HSP finding approaches: using the protein sequence
encoded by the query gene and the target genomic sequence (the protein-nucleotide alignment
approach), and using the CDS of the query gene and the target genomic sequence (the
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BLASTN TBLASTN
M. musculus 100% 100%
C. elegans 37.0% 91.5%
Table 3.6: Sensitivity of finding relevant HSPs (BLASTN v.s. TBLASTN)
nucleotide alignment approach). We used TBLASTN [25, 40] as an implementation of the
protein-nucleotide alignment approach, and BLASTN [25, 40] as an implementation of the
nucleotide alignment approach. For both approaches, we computed the sensitivity that at
least one of the HSPs overlap at least one of the exons of the target gene, and compared the
sensitivitys between the two approaches.
To compare the two approaches, we used the homologous gene groups in the training
data set, as explained in Section 3.1.2. We first used the mouse genes, and then the C.
elegans genes in the training data set as query genes to find HSPs. We found the HSPs
between the protein sequence encoded by the query gene and the target genomic sequence
with TBLASTN, and the HSPs between the CDS of the query gene and the target genomic
sequence with BLASTN. Since we do not allow gaps in HSPs, as stated in Section 2.1, we
used “-nogaps” to disable gaped alignments in TBLASTN and BLASTN. In this experiment,
we simply used all HSPs found by TBLASTN and BLASTN without filtering.
Table 3.6 shows that when using mouse query genes, both TBLASTN and BLASTN
found HSPs that overlap all target genes. The situation is not so good in case of C. elegans
query genes. TBLASTN still found relevant HSPs with high sucess rate (91.5%). However,
BLASTN failed to find relevant HSPs in most cases (true positive rate only 37.0%). This
means that BLASTN is not sufficient to find relevant HSPs to locate accurate target regions,
because we are not able to find at least one of the HSPs that overlaps at least one of the
exons of the target gene in most cases.
The experiment results suggest two things. First, the protein-nucleotide approach is
sufficient to find at least one of the HSPs that overlap at least one of the exons of the
target gene. Second, when the query and target genes are from close species, the nucleotide
alignment approach is as sufficient as the protein-nucleotide alignment approach, which is
much slower. Therefore, we use the protein-nucleotide approach in our homologous gene
finding algorithm in the following experiments for better accuracy.
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Threshold 25 35 45 55 65 75 85
M. musculus 1.06 1.42 1.75 1.80 1.76 1.71 1.67
C. elegans 1.75 1.46 1.76 1.79 1.76 1.71 1.67
Table 3.7: Choosing a threshold to maximize the value of Equation (2.1)
3.4 Filtering HSPs
In this experiment, we studied the effects of filtering HSPs before locating target regions.
Let a useful HSP be an HSP that overlaps at least one of the exons of the target gene, and
a noise HSP be an HSP that does not overlap any exon of the target gene. We first chose
a threshold in the way described in Section 2.1, and then evaluated the effects of filtering
on the sensitivity that the predicted target region contains the target gene. Here, we say
a target region contains the target gene if and only if there is a useful HSP in the target
region.
Recall that we want to choose a threshold to maximize the value of Equation (2.1), so
that most of noise HSPs are filtered out, and most of useful HSPs are retained. Thus, we
used the homologous gene groups in the training data set, as explained in Section 3.1.2,
and filtered HSPs with thresholds from 0 to 110 with a step size 5. For each threshold, we
counted the numbers of useful HSPs and the number of noise HSPs before and after filtering,
and computed the value of Equation (2.1). Some results are shown in Table 3.7. From the
table, we chose a threshold of 55, which maximized the value of Equation (2.1).
Table 3.8 shows that the numbers of useful HSPs and the number of noise HSPs before
and after filtering with a threshold of 55. When using mouse query genes, 85.28% of noise
HSPs were filtered out, and 96.70% of useful HSPs were retained. Before filtering, useful
HSPs weighted only 0.79% over all HSPs. After filtering, useful HSPs weighted 5.02%. Thus,
we increased the weight of useful HSPs significantly from 0.79% to 5.02%. When using C.
elegans query genes, 86.85% of noise HSPs were filtered out, and 89.00% of useful HSPs were
retained. We increased the weight of useful HSPs significantly from 0.73% to 4.73%. Since
the weight of useful HSPs was increased significantly, it was more likely to find the correct
target region.
To study the effects of filtering on locating target regions, we predicted a target region
using the highest scoring cluster before and after filtering with thresholds of 0, 45, 55, 65
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Before Filtering After Filtering
#Useful HSPs #Noise HSPs #Useful HSPs #Noise HSPs
M. musculus 2365 294116 2287 43296
C. elegans 1610 219344 1433 28834
Table 3.8: Filtering HSPs with a threshold of 55
Threshold 0 45 55 65 110
M. musculus 89.0% 92.0% 93.0% 93.0% 90.5%
C. elegans 70.5% 72.0% 70.5% 72.0% 61.5%
Table 3.9: Sensitivity of filtering HSPs with different thresholds
and 110. Then, we computed the sensitivity that the predicted target region contains the
target gene.
Table 3.9 shows that before filtering (threshold = 0), we located 89.0% of the target
regions correctly when using mouse query genes, and 70.5% of the target regions correctly
when using C. elegans query genes. After filtering with a threshold of 55, we located 93.0%
of the target regions correctly when using mouse query genes, and 70.5% of the target regions
correctly when using C. elegans query genes. These numbers did not change much when
thresholds of 45 and 65 were used, but dropped to 90.5% and 61.5% when a threshold of 110
was used.
Therefore, we can conclude that filtering HSPs increases the accuracy of target region
locating when the query and target genes are from close species. Recall that we want to
keep most of the useful HSPs so that we can use these HSPs in the gene finding step to
improve the accuracy in the future. The experiments results show that choosing the filtering
threshold to maximize the value of Equation (2.1) does not harm the accuracy of locating
target regions much. In the following sections, we filter HSPs with a threshold of 55 as a
default.
3.5 Using Multiple Target Regions
In this experiment, we studied the effects of using multiple target regions. We used the
homologous gene groups in the training data set, as explained in Section 3.1.2, and clustered
the filtered HSPs. Then, we located 1, 3, 5, 7 and 9 target regions from the highest scoring
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#Target Regions 1 3 5 7 9
M. musculus 93.0% 98.5% 99.0% 99.0% 99.5%
C. elegans 70.5% 87.5% 88.5% 88.5% 89.5%
Table 3.10: Sensitivity of using different number of target regions
#Initiators 1 2 3 4 5
M. musculus 97.5% 98.5% 98.5% 98.5% 98.5%
C. elegans 86.0% 87.5% 87.5% 87.5% 87.5%
Table 3.11: Sensitivity of using different number of initiators
HSP clusters, as explained in Section 2.2. Finally, we computed the sensitivity that we found
the true target region containing the target gene.
Table 3.10 shows that when we used only the highest scoring cluster to locate a target
region, we located 93.0% of the true target regions for mouse query genes, and 70.5% of the
true target regions for C. elegans query genes. The sensitivity was increased to 98.5% for
mouse query genes, and 87.5% for C. elegans query genes, when the number of clusters was
increased to three. In general, the sensitivity increases slowly with the increasing number of
target regions.
The experiment results suggest that using multiple target regions improves the accuracy
of locating target regions. To achieve a good accuracy without slowing down the computa-
tion much, we used three target regions as a default in our implementation and following
experiments.
3.6 Using Multiple Initiators for Each Target Region
In this experiment, we studied the effects of using multiple initiators for each target regions
by computing the sensitivity that at least one initiator hits the target gene. We used the
homologous gene groups in the training data set, as explained in Section 3.1.2, and located
three target regions from the top three scoring HSP clusters. Then, we chose 1, 2, 3, 4 and
5 initiators for each target region, as explained in Section 2.2.
Table 3.11 shows that when we chose a single initiator for each target region, 97.5% of
the initiators hit the target gene for mouse query genes, and 86.0% of the initiators hit the
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target gene for C. elegans query genes. These numbers were increased to 98.5% and 87.5%
when we chose two initiators for each target region, and remain the same when we chose
more than two initiators for each target region. When using a single initiator, we observed
five cases where we chose incorrect initiators within correct target regions.
The experiment results suggest that using multiple initiators may improve the accuracy
of locating target regions. In the following sections, we use three initiators for each target
region as a default in order to achieve a good accuracy without slowing down the computation
much.
3.7 HMM Probabilities to be Biased
In this section, we study which HMM probabilities should be biased. If biasing the HMM
probabilities of a state toward the query gene boosts the HMM probabilities of target genes,
we should bias the HMM probabilities of the state. Otherwise, we should not bias the HMM
probabilities of the state. In the next section, we study if the biased training improves the
accuracy of homologous gene finding.
For each pair of query and target genes, we first trained the HMM probabilities with
the target gene, and then with the query gene. We say that the HMM probabilities trained
with the target gene are the true HMM probabilities we seek to estimate, and the HMM
probabilities trained with the query gene are the estimations of the true HMM probabilities,
or estimated HMM probabilities. In fact, the true HMM probabilities are likely the best
HMM probabilities to find the target gene. We should bias the HMM probabilities of a
state, if we are likely to bias the HMM probabilities toward the true HMM probabilities by
biasing the HMM probabilities toward the estimated HMM probabilities.
To study which HMM probabilities should be biased, we computed the root mean square
error (RMSE) of the estimated HMM probabilities using the homologous gene groups in the
training data set, as explained in Section 3.1.2. Since the emission probabilities are inde-
pendent of the transition probabilities, we computed the RMSE of the emission probabilities
and the RMSE of the transition probabilities separately for each state. In order to increase
numerical reliability, we used the logarithms of the HMM probabilities, and thus we com-
puted RMSEs of the logarithms of the HMM probabilities. If the computed RMSE is small,
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M. musculus C. elegans
AVG STDEV AVG STDEV
exon[1] 0.05 0.27 1.00 0.85
exon[2] 0.08 0.35 0.98 0.84
exon[3] 0.07 0.31 0.65 0.60
Table 3.12: RMSE of logarithms of transition probabilities of exon states
M. musculus C. elegans
AVG STDEV AVG STDEV
intron[1] 0.33 0.70 2.81 1.71
intron[2] 0.34 0.71 2.59 1.65
intron[3] 0.35 0.72 2.39 1.42
Table 3.13: RMSE of logarithms of transition probabilities of intron states
the estimated HMM probabilities are good estimations of the true HMM probabilities. This
also implies that if we bias the HMM probabilities toward the estimated HMM probabili-
ties, we will successfully bias the HMM probabilities toward the true HMM probabilities.
Otherwise, we will move the HMM probabilities away from the true HMM probabilities.
Therefore, if both the average (AVG) and standard derivation (STDEV) of the computed
RMSEs of a state are small, we are likely to bias the HMM probabilities of the state toward
the true HMM probabilities by biasing the HMM probabilities toward the estimated HMM
probabilities.
The experiment results are shown in Table 3.12 to Table 3.4. Comparisons of the numbers
in these tables show which HMM probabilities are more likely to be conserved between
homologous genes. Generally, the HMM probabilities with smaller average and standard
derivation of RMSEs are more likely to be conserved, and the HMM probabilities with
larger average and standard derivation of RMSEs are less likely to be conserved. However,
we cannot conclude that the emission probabilities of higher order states are more likely to
be conserved than those of lower order states based on only the comparisons of the average
and standard derivation of RMSEs. This is mainly because the higher order states have
more emission probabilities, and the RMSEs of more emission probabilities of higher order
states tend to be larger and more unreliable.
Tables 3.12 and 3.13 show that coding exon and intron lengths of mouse genes are more
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M. musculus C. elegans
AVG STDEV AVG STDEV
exon[1] 0.61 0.10 0.80 0.10
exon[2] 0.53 0.11 0.77 0.10
exon[3] 0.62 0.11 0.82 0.12
Table 3.14: RMSE of logarithms of emission probabilities of exon states
M. musculus C. elegans
AVG STDEV AVG STDEV
intron[1] 0.73 0.30 0.96 0.38
intron[2] 0.69 0.34 0.90 0.40
intron[3] 0.77 0.25 1.10 0.30
Table 3.15: RMSE of logarithms of emission probabilities of intron states
likely to be conserved to their homologous human genes than C. elegans genes. Comparison
of Tables 3.12 and 3.13 shows that intron lengths are not as well conserved as coding exon
lengths, because the average and standard derivation of RMSEs of logarithms of transition
probabilities of introns states are much higher than exon states.
Tables 3.14 and 3.15 show that coding exons and introns of mouse genes are more likely
to be conserved to their homologous human genes than C. elegans genes. We also observed
that the probabilities of the nucleotides in the first codon frame are more likely to be con-
served than those of the nucleotides in other codon frames between mouse genes and their
homologous human genes. However, the probabilities of the nucleotides in the third codon
frame are more likely to be conserved than those of the nucleotides in other codon frames
between C. elegans genes and their homologous human genes. Comparison of Tables 3.14
and 3.15 shows that introns are not as well conserved as coding exons, because average and
standard derivation of RMSEs of logarithms of emission probabilities of introns states are
much higher than exon states.
Figures 3.1 and 3.2 show that the signals within coding exons around acceptor splice
sites are more likely to be conserved than the signals within introns, and the signals near
splice sites are more likely to be conserved than the signals distant from splice sites. We also
observed that for splice site signal states, AVG RMSE of logarithms of emission probabilities
for mouse query genes is usually smaller than that for C. elegans query genes, but STDEV
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Figure 3.1: RMSE of logarithms of emission probabilities of acceptor signal states
Figure 3.2: RMSE of logarithms of emission probabilities of donor signal states
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RMSE of logarithms of emission probabilities for mouse query genes is usually larger than
that for C. elegans query genes.
Figures 3.3 and 3.4 show that the signals within coding exons around start and stop sites
are more likely to be conserved than the signals within introns, and the signals near start
and stop sites are more likely to be conserved than the signals distant from start and stop
sites. We also observed that for start and stop signal states, AVG RMSE of logarithms of
emission probabilities for mouse query genes is usually smaller than that for C. elegans query
genes, but STDEV RMSE of logarithms of emission probabilities for mouse query genes is
usually larger than for C. elegans query genes.
Tables 3.12 and 3.13 suggest that we should not bias transition probabilities, because the
biased training tends to unreliable (large average and standard derivation of RMSEs) when
the query and target genes are from distant species. Tables 3.14 and 3.15 suggest that we
should not bias emission probabilities of intron states, because they are not as well conserved
as those of exon states. In fact, our research on biased training is very preliminary, and there
is obviously a lot of work to do. We are considering other approaches to study which HMM
probabilities should be biased, such as entropy. We are also trying to model the correlations
between the true HMM probabilities and the estimated HMM probabilities into the biased
training. In the current implementation of our homologous gene finding algorithm, we bias
only the emission probabilities of the exon and signal states.
3.8 Biased Training
In this experiment, we evaluated the effects of the biased training introduced in Section 2.2.
We used the homologous gene groups in the testing data set, as explained in Section 3.1.2.
In order to avoid the effects of incorrect initiators, we used the ideal initiator of the true
target region to find homologous genes. As stated earlier, the ideal initiator is located in the
middle of the CDS of the target gene in the target genomic sequence. Then, we set the weight
constant W , as introduced in Equations (2.2) and (2.3), to the values 0 (unbiased), 0.25,
0.5 and 0.75, and found gene candidates, as described in Section 2.3. Finally, we used the
program Eval [10] to compute the sensitivity (SN) and specificity (SP ) of our homologous
gene finding (see Section 1.2 for the definitions of these metrics).
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Figure 3.3: RMSE of logarithms of emission probabilities of start signal states
Figure 3.4: RMSE of logarithms of emission probabilities of stop signal states
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W Gene SN / SP Exon SN / SP Nucleotide SN / SP
0 (unbiased) 14.50% / 14.50% 42.07% / 52.35% 55.86% / 56.65%
0.25 42.00% / 42.00% 75.74% / 80.85% 83.22% / 83.07%
0.5 47.75% / 47.75% 79.69% / 82.87% 86.27% / 86.63%
0.75 47.00% / 47.00% 79.93% / 82.06% 86.65% / 86.96%
1.0 44.25% / 44.25% 78.28% / 80.58% 85.04% / 85.46%
Table 3.16: Sensitivity and specificity of the biased training with different weights (M.
musculus)
W Gene SN / SP Exon SN / SP Nucleotide SN / SP
0 (unbiased) 14.50% / 14.50% 42.07% / 52.35% 55.86% / 56.65%
0.25 5.00% / 5.00% 30.77% / 38.03% 49.56% / 50.32%
0.5 3.50% / 3.50% 19.42% / 25.55% 37.16% / 38.14%
0.75 1.75% / 1.75% 10.97% / 16.36% 25.34% / 26.23%
1.0 0.75% / 0.75% 6.59% / 11.27% 17.26% / 18.07%
Table 3.17: Sensitivity and specificity of the biased training with different weights (C. ele-
gans)
Since we used only the very simple HMM shown in Figure 2.2, the sensitivity and speci-
ficity of our homologous gene finding algorithm is not as good as other single-genome gene
finding algorithms, such as GENSCAN [9] and AUGUSTUS [34]. Using the 178 human
genes in the data set sag178 [34], AUGUSTUS has an exon sensitivity of 78% and an exon
specificity of 71%, while GENSCAN has an exon sensitivity of 68% and an exon specificity of
45%. Table 3.16 shows that our homologous gene finding algorithm without biased training
has an exon sensitivity of only 42.28% and an exon specificity of only 52.54%. However, this
is not a major concern, because we are interested in studying the effects of the biased train-
ing, not in finding the best HMM. Certainly, we will improve the HMM used for homologous
gene finding in the future.
Table 3.16 shows that the sensitivity and specificity are improved significantly after using
mouse genes in the biased training. When using W = 0.5, the best exon sensitivity of 79.69%
and the best exon specificity of 82.87% are archieved. Table 3.16 also shows that the benefit
of the biased training is not maximized when using small values of W , and overfitting occurs
when using large values of W . Table 3.17 shows that the sensitivity and specificity drop
after using C. elegans query genes in the biased training. Even worse, while we increase the
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effects of the biased training by increasing W , the sensitivity and specificity decrease.
The experiment results suggest that when the query and target genes are from close
species, the biased training improves the sensitivity and specificity of homologous gene find-
ing. Moreover, the sensitivity and specificity can still be improved using more advanced
HMMs, such as the ones used by GENSCAN [9] and AUGUSTUS [34]. However, the experi-
ment results show that when the query and target genes are from distant species, our current
biased training approach does not improve the sensitivity and specificity of homologous gene
finding. We are still looking for other ways to bias the HMM probabilities toward the query
genes for the query and target genes from distant species.
3.9 Complete CDS Length v.s. Gene Length
In this section, we study how the CDS lengths and the gene lengths differ between homol-
ogous genes. Thus, we computed the CDS length difference and the gene length difference
between each pair of homologous genes in the training data set.
The results are shown from Figure 3.5 to Figure 3.8. Figures 3.5 and 3.6 show that the
CDS length of homologous genes are conserved, and the distribution fits the normal distri-
bution well. Comparison of Figures 3.5 and 3.6 shows that the CDS length of homologous
genes from distant species are not as well conserved as those from close species. Figures 3.7
and 3.8 show that the gene length of homologous genes is not conserved, and human genes
are generally longer than mouse and C. elegans genes.
Recall that we approximate the distribution of the CDS length of the target gene with a
normal distribution with mean µ ≈ λ5′ and variance σ2 ≈ 2λ5′ , where λ5′ is the CDS length
of the query gene. The results suggest that the approximation with a normal distribution
is reasonable. However, the results also suggest that the variance of the normal distribution
should depend on the distance between the query and target species. Thus, we will use this
information to adjust the variance in the future.
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Figure 3.5: Complete CDS length difference distribution (H. sapiens v.s. M. musculus)
Figure 3.6: Complete CDS length difference distribution (H. sapiens v.s. C. elegans)
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Figure 3.7: Gene length difference distribution (H. sapiens v.s. M. musculus)
Figure 3.8: Gene length difference distribution (H. sapiens v.s. C. elegans)
54
Exon SN / SP Nucleotide SN / SP Runtime
with M. musculus 79.69% / 82.87% 86.27% / 86.63% 32.19s
CDSLP C. elegans 19.42% / 25.55% 37.16% / 38.14% 35.94s
without M. musculus 1.48% / 7.38% 8.72% / 69.72% 51.06s
CDSLP C. elegans 0.72% / 3.53% 7.30% / 64.45% 43.65s
Table 3.18: Sensitivity and specificity of the CDS length penalty and the stopping condition
3.10 CDS Length Penalty and Stopping Condition
To study the effects of the CDS length penalty (CDSLP) and the stopping condition, we
used homologous gene groups in the testing data, as explained in Section 3.1.2. We used the
ideal initiator and W = 0.5 to find a homologous gene candidate for each query gene with
and without the CDS length penalty and the stopping condition. We run our homologous
gene finding implementation on a computer with a 1.4GHz Intel Xeon CPU, and recorded
the average running time (CPU time) per query gene. The running time does not include
the time required to find HSPs between the protein sequence encoded by the query gene
and the target genomic sequence. Finally, we used Eval [16] to compute sensitivity SN and
specificity SP of homologous gene finding.
The experiment results in Table 3.18 show that the sensitivity and specificity of homol-
ogous gene finding without the CDS length penalty are very poor. We observed that our
HMM favors short gene structures. As a result, when using mouse query genes without
the CDS length penalty, the average length of predicted genes is 465, while the true average
length is 36537. Table 3.18 also shows that using the stopping condition, the average running
time to find homologous genes is reduced 37.0%.
The experiment results suggest that using the CDS length penalty and the stopping
condition helps to achieve better sensitivity and specificity, and to reduce running time of
our homologous gene finding algorithm.
3.11 Gene Candidate Assessment
In this experiment, we compared two gene candidate assessment approaches using the ho-
mologous gene groups, as described in Section 3.1.2. The first approach is to choose and
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Gene SN / SP Exon SN / SP Nucleotide SN / SP
Protein M. musculus 33.25% / 33.25% 74.45% / 76.80% 82.29% / 83.51%
Alignment C. elegans 0.25% / 0.27% 13.65% / 18.46% 26.03% / 29.98%
Nucleotide M. musculus 33.25% / 33.25% 74.45% / 76.80% 82.29% / 83.51%
Alignment C. elegans 0.25% / 0.27% 13.65% / 18.46% 26.03% / 29.98%
Table 3.19: Sensitivity and specificity of gene candidate assessment (protein alignment v.s.
nucleotide alignment)
rank gene candidates using the global alignment between the proteins encoded by the query
gene and the gene candidate (the protein alignment approach). The second approach is to
choose and rank gene candidates using the global alignment between the CDS of the query
gene and the gene candidate (the nucleotide alignment approach). We used Eval [16] to
compute the sensitivity and specificity of the highest ranked homologous gene.
Table 3.19 shows that both approaches have the same sensitivity and specificity. In our
homologous gene finding algorithm and implementation, we choose and rank gene candidates




Conclusion and Future Work
In this thesis, we introduced the homologous gene finding problem and our new algorithm
to solve this problem. The algorithm takes a query gene and a target genomic sequence as
input, and then finds all homologous genes of the query gene in the target genomic sequence.
We implemented and evaluated the performance of our homologous gene finding algorithm.
We also showed that the homologous gene finding problem can be solved by applying and
extending existing seed-based homology search algorithms and HMM-based gene finding
algorithms.
4.1 Comparison to GeneWise [5] and Projector [24]
Compared to GeneWise [5] and Projector [24], our proposed homologous gene finding algo-
rithm has three strengths. First, we train a simple single-genome gene finding HMM to be
biased toward the query gene. Using the biased training, we can achieve comparative sensi-
tivity and specificity without using complicated and computationally intensive pair-HMMs.
Second, we use the approximate CDS length distribution of the target gene to further im-
prove the sensitivity and specificity. In fact, finding correct start and stop codons is the most
challenging part of gene finding, and the approximated CDS length distribution is designed
directly to conquer this challenge. Third, we locate target regions which might contain target
genes, and then find target genes in the target regions. This approach is more efficient than
filtering homologous genes after finding target genes on the entire target genomic sequence.
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This is because seed-based homology search algorithms are not as computationally intensive
as gene finding algorithms, and we can locate target regions very fast using HSPs found by
a seed-based homology search algorithm.
4.2 Future Work
Our homologous gene finding algorithm works well when the query and the target genes are
from close species, but there is still space for improvements.
First, we can certainly improve the sensitivity and specificity of homologous gene finding
by using a more advanced HMM.
Second, we will further study which HMM probabilities should be biased, and model the
correlations between the true HMM probabilities and the estimated HMM probabilities into
the biased training.
Third, we will bias the HMM probabilities toward all possible complete CDSs that en-
codes the protein encoded by the query gene. This might improve the sensitivity and speci-
ficity of homologous gene finding, when the query and target genes are from distant species.
Fourth, we will model the distance between the query and target species into the CDS
length penalty, as the experiment results suggested in Section 3.9.
Finally, we will model the alignment information into the HMM-based gene finding pro-
cess. Current research on dual-genome gene finding algorithms [19, 11, 29] shows that adding
alignment probabilities into HMM probabilities can improve both the sensitivity and speci-
ficity of gene finding.
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